Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on: January 02,2024

Incidence of cutaneous T-cell lymphoma up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018, according to a research letter published online Sept. 1 inJAMA Oncology.Zhuo Ran Cai,

Updated on:January 02,2024

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c

Updated on: May 17,2024

Doctors call for expanded reporting of medical care given in Immigration and Customs Enforcement detention centers

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainA newstudyled by Dr. Annette Dekker, an assistant professor in the Department of Emergency Medicine at UCLA, c

Updated on:May 17,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on: January 12,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on:January 12,2024

Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

by European Organisation for Research and Treatment of CancerA patient exercising as part of the clinical trial. Credit: EORTC / Anouk HienschTaking part in an exercise program reduced pain and fatigu

Updated on: March 30,2024

Exercise shown to help patients with advanced breast cancer, especially if they are suffering with pain

by European Organisation for Research and Treatment of CancerA patient exercising as part of the clinical trial. Credit: EORTC / Anouk HienschTaking part in an exercise program reduced pain and fatigu

Updated on:March 30,2024

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

by Julia Moióli,FAPESPAbstract. Credit:Journal of Proteome Research(2022). DOI: 10.1021/acs.jproteome.2c00630Preclinical trials have shown that zika virus can inhibit the spread of p

Updated on: January 28,2024

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

by Julia Moióli,FAPESPAbstract. Credit:Journal of Proteome Research(2022). DOI: 10.1021/acs.jproteome.2c00630Preclinical trials have shown that zika virus can inhibit the spread of p

Updated on:January 28,2024

Are older women being over-screened for cervical cancer?

byUniversity of Illinois at ChicagoCredit: CC0 Public DomainA new study published inJAMA Internal Medicinesuggests that women over the age of 65 may be undergoing unnecessary cervica

Updated on: December 28,2023

Are older women being over-screened for cervical cancer?

byUniversity of Illinois at ChicagoCredit: CC0 Public DomainA new study published inJAMA Internal Medicinesuggests that women over the age of 65 may be undergoing unnecessary cervica

Updated on:December 28,2023

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on: January 30,2024

Transforming cancer diagnosis and treatment with cerium/lanthanum-134

by US Department of EnergyCerium/lanthanum-134-based radiopharmaceuticals have promise for prostate cancer imaging and therapy. Right, tumors show high tumor uptake of cerium-134. Left, a compari

Updated on:January 30,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on: February 01,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on:February 01,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on: June 28,2024

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on:June 28,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on: May 11,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on:May 11,2024